Novel Genetic Switches Make Gene Therapies Safer and More Effective -Financieel Dagblad Interview (Nov 2024)

Article as featured in the Financieel Dagblad (Financial Times), 29 November 2024 (link)

UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters

Dec 12, 2024

UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters Annogen, a leader in gene expression engineering, and the prestigious labs of Qizhi Tang and Brian Shy at University of California, San Francisco (UCSF) today announced a collaboration...

SuRE™ promoter screening: customizing your therapy for improved safety and efficacy

Oct 1, 2024

The development of cell and gene therapies is a complex and time-consuming process that depends on therapeutic genes being expressed in the right tissues, at the right time and at the right dosage.

Technology

Solutions

Annogen

SuRE™

Survey for Regulatory Elements

AIM™

Annogen Integration Site Mapping

Cell & Gene Therapy

Promoter engineering

Off-the-shelf-promoters

Promoter optimization

Expression site identification

Crop Engineering

Functional genome analysis

Manufacturing Cell Lines

Promoter engineering

Off-the-shelf-promoters

Promoter optimization

Expression site identification

Novel Genetic Switches Make Gene Therapies Safer and More Effective -Financieel Dagblad Interview (Nov 2024)

UCSF, Annogen Announce Collaboration to Identify Superior Treg-Specific Promoters

SuRE™ promoter screening: customizing your therapy for improved safety and efficacy

Technology

Solutions

Annogen

SuRE™

AIM™

Cell & Gene Therapy

Crop Engineering

Manufacturing Cell Lines

Home

About us

News

Insights

Contact

Technology

Solutions

Annogen

SuRE™

AIM™

Cell & Gene Therapy

Crop Engineering

Manufacturing Cell Lines

Home

About us

News

Insights

Contact